Literature DB >> 17458650

Tobacco control for anesthesiologists.

David O Warner1.   

Abstract

Anesthesiologists daily witness the consequences of tobacco use, the most common preventable cause of death. Smoking-related diseases such as atherosclerosis and chronic obstructive pulmonary disease increase anesthetic risk, and even smokers without overt disease are at increased risk for morbidity such as pulmonary and wound-related complications. Evidence suggests that stopping smoking will reduce the frequency of these complications. Nicotine and the other constituents of cigarette smoke, such as carbon monoxide, have important physiologic effects that may affect perioperative management. In addition, it is now apparent that the scheduling of elective surgery represents an excellent opportunity for smokers to quit in the long term. This review serves as an introduction to tobacco control for anesthesiologists, first examining issues of importance to perioperative management. It then discusses how anesthesiologists and other perioperative physicians can help address tobacco use, both at an individual level with their patients, and by contributing to the implementation of effective public health strategies in their countries. Anesthesiologists can play a key role in helping their patients quit smoking. Effective tobacco control measures applied to surgical patients will not only improve immediate perioperative outcomes but also long-term health.

Entities:  

Mesh:

Year:  2007        PMID: 17458650     DOI: 10.1007/s00540-006-0483-9

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  155 in total

1.  Varenicline.

Authors:  Raymond Niaura; Carole Jones; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2006-07       Impact factor: 84.694

Review 2.  The role of nicotine in smoking-related cardiovascular disease.

Authors:  N L Benowitz
Journal:  Prev Med       Date:  1997 Jul-Aug       Impact factor: 4.018

3.  Control of haemodynamic response to tracheal intubation in cigarette smokers compared with non-smokers.

Authors:  S Paventi; A Santevecchi; R Ranieri
Journal:  Eur Rev Med Pharmacol Sci       Date:  2001 May-Jun       Impact factor: 3.507

4.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

Authors:  J D Morrow; B Frei; A W Longmire; J M Gaziano; S M Lynch; Y Shyr; W E Strauss; J A Oates; L J Roberts
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

5.  Sensitivity of upper airway reflexes in cigarette smokers: effect of abstinence.

Authors:  R J Erskine; P J Murphy; J A Langton
Journal:  Br J Anaesth       Date:  1994-09       Impact factor: 9.166

6.  Effect of nicotine replacement therapy on stress and smoking behavior in surgical patients.

Authors:  David O Warner; Christi A Patten; Steven C Ames; Kenneth P Offord; Darrell R Schroeder
Journal:  Anesthesiology       Date:  2005-06       Impact factor: 7.892

7.  The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.

Authors:  A M Joseph; S M Norman; L H Ferry; A V Prochazka; E C Westman; B G Steele; S E Sherman; M Cleveland; D O Antonuccio; D O Antonnucio; N Hartman; P G McGovern
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

8.  Perioperative respiratory events in smokers and nonsmokers undergoing general anaesthesia.

Authors:  B Schwilk; U Bothner; S Schraag; M Georgieff
Journal:  Acta Anaesthesiol Scand       Date:  1997-03       Impact factor: 2.105

9.  Smoking behavior and perceived stress in cigarette smokers undergoing elective surgery.

Authors:  David O Warner; Christi A Patten; Steven C Ames; Kenneth Offord; Darrell Schroeder
Journal:  Anesthesiology       Date:  2004-05       Impact factor: 7.892

Review 10.  The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation.

Authors:  B W M Willemse; D S Postma; W Timens; N H T ten Hacken
Journal:  Eur Respir J       Date:  2004-03       Impact factor: 16.671

View more
  2 in total

Review 1.  Surgical smoke and the anesthesia provider.

Authors:  Barry N Swerdlow
Journal:  J Anesth       Date:  2020-04-15       Impact factor: 2.078

2.  Perioperative smoking cessation in vascular surgery: challenges with a randomized controlled trial.

Authors:  Mette Kehlet; Sabine Heeseman; Hanne Tønnesen; Torben V Schroeder
Journal:  Trials       Date:  2015-10-05       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.